These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

35 related items for PubMed ID: 2272281

  • 1. [The structure-function relationships in alpha-interferons. A study of the antiviral activity of mutant forms of human alpha 2-interferon].
    Shekhter II, Bulenkov MT, Veĭko VP, Ratmanova KI, Evdonina LV, Kulakova OG, Iurin VL, Debabov VG.
    Dokl Akad Nauk SSSR; 1990; 314(4):998-1001. PubMed ID: 2272281
    [No Abstract] [Full Text] [Related]

  • 2. [Antiviral activity of mutant interferons. A new approach to the study of structural-functional organization of interferons].
    Petrenko VA, Tat'kov SI, Sivolobova GF, Boldyrev AN, Kolokol'tsev AA.
    Bioorg Khim; 1987 Feb; 13(2):259-62. PubMed ID: 3555509
    [Abstract] [Full Text] [Related]

  • 3. Single amino acid substitutions at conserved residues of human interferon-alpha can effect antiviral specific activity.
    Nisbet IT, Beilharz MW, Hertzog PJ, Tymms MJ, Linnane AW.
    Biochem Int; 1985 Sep; 11(3):301-9. PubMed ID: 3904757
    [Abstract] [Full Text] [Related]

  • 4. Shared receptor components but distinct complexes for alpha and beta interferons.
    Lewerenz M, Mogensen KE, Uzé G.
    J Mol Biol; 1998 Sep 25; 282(3):585-99. PubMed ID: 9737924
    [Abstract] [Full Text] [Related]

  • 5. Functional significance of globotriaosyl ceramide in interferon-alpha(2)/type 1 interferon receptor-mediated antiviral activity.
    Khine AA, Lingwood CA.
    J Cell Physiol; 2000 Jan 25; 182(1):97-108. PubMed ID: 10567921
    [Abstract] [Full Text] [Related]

  • 6. The in vivo and in vitro effects of chicken interferon alpha on infectious bursal disease virus and Newcastle disease virus infection.
    Mo CW, Cao YC, Lim BL.
    Avian Dis; 2001 Jan 25; 45(2):389-99. PubMed ID: 11417818
    [Abstract] [Full Text] [Related]

  • 7. Cloning, expression and biological activity of a new variant of human interferon alpha identified in virus induced lymphoblastoid cells.
    Cohen S, Velan B, Grosfeld H, Shalita Z, Leitner M, Shafferman A.
    Dev Biol Stand; 1985 Jan 25; 60():111-22. PubMed ID: 2995168
    [Abstract] [Full Text] [Related]

  • 8. Regulation of natural killer cytotoxicity by recombinant alpha interferons. Augmentation by IFN-alpha 7, an interferon similar to IFN-alpha J.
    Platsoucas CD, Fox FE, Oleszak E, Fong K, Nanno M, Ioannides CG, Trotta PP.
    Anticancer Res; 1989 Jan 25; 9(4):849-58. PubMed ID: 2817813
    [Abstract] [Full Text] [Related]

  • 9. Independent evolution of antiviral and growth-modulating activities of interferon.
    Carter WA, Swartz H, Gillespie DH.
    J Biol Response Mod; 1985 Oct 25; 4(5):447-59. PubMed ID: 2416881
    [Abstract] [Full Text] [Related]

  • 10. Comparative in vivo and in vitro activation of human natural killer cells by two recombinant alpha-interferons differing in antiviral activity.
    Edwards BS, Hawkins MJ, Borden EC.
    Cancer Res; 1984 Jul 25; 44(7):3135-9. PubMed ID: 6586292
    [Abstract] [Full Text] [Related]

  • 11. Antibody-fused interferons as an effective approach to enhance target specificity and antiviral efficacy of type I interferons.
    Cheng LS, Hwang S, Huang TH, Sheu TC, Sun R, Morrison SL, Cheng G, Shahangian A.
    Cell Res; 2008 Dec 25; 18(12):1230-2. PubMed ID: 19002159
    [No Abstract] [Full Text] [Related]

  • 12. Human interferons alpha, beta and omega.
    Bekisz J, Schmeisser H, Hernandez J, Goldman ND, Zoon KC.
    Growth Factors; 2004 Dec 25; 22(4):243-51. PubMed ID: 15621727
    [Abstract] [Full Text] [Related]

  • 13. Mutational and structural analysis of the binding interface between type I interferons and their receptor Ifnar2.
    Piehler J, Schreiber G.
    J Mol Biol; 1999 Nov 19; 294(1):223-37. PubMed ID: 10556041
    [Abstract] [Full Text] [Related]

  • 14. Antiviral potential of interferon-omega on hepatitis B virus replication in human hepatoma cells.
    Hagelstein J, Kist A, Stremmel W, Galle PR.
    Arzneimittelforschung; 1998 Mar 19; 48(3):343-7. PubMed ID: 9553691
    [Abstract] [Full Text] [Related]

  • 15. Antiviral activity of CHO-SS cell-derived human omega interferon and other human interferons against HCV RNA replicons and related viruses.
    Buckwold VE, Wei J, Huang Z, Huang C, Nalca A, Wells J, Russell J, Collins B, Ptak R, Lang W, Scribner C, Blanchett D, Alessi T, Langecker P.
    Antiviral Res; 2007 Feb 19; 73(2):118-25. PubMed ID: 16987555
    [Abstract] [Full Text] [Related]

  • 16. [Anti-viral proteins: from interferon alpha to its receptor].
    Chieux V, Hober D, Chehadeh W, Wattr P.
    Ann Biol Clin (Paris); 1999 May 19; 57(3):283-90. PubMed ID: 10377478
    [Abstract] [Full Text] [Related]

  • 17. Design, characterization, and structure of a biologically active single-chain mutant of human IFN-gamma.
    Landar A, Curry B, Parker MH, DiGiacomo R, Indelicato SR, Nagabhushan TL, Rizzi G, Walter MR.
    J Mol Biol; 2000 May 26; 299(1):169-79. PubMed ID: 10860730
    [Abstract] [Full Text] [Related]

  • 18. [Alfa-interferons. Genetically engineered Antivirals].
    Dingermann T, Zündorf I.
    Pharm Unserer Zeit; 2011 Jan 26; 40(1):68-77. PubMed ID: 21194085
    [No Abstract] [Full Text] [Related]

  • 19. [Structure-activity organization of leukocytic interferon].
    Petrenko VA, Tat'kov SI.
    Mol Biol (Mosk); 1990 Jan 26; 24(6):1495-503. PubMed ID: 2094805
    [Abstract] [Full Text] [Related]

  • 20. Alpha and beta interferons and their receptor and their friends and relations.
    Uzé G, Lutfalla G, Mogensen KE.
    J Interferon Cytokine Res; 1995 Jan 26; 15(1):3-26. PubMed ID: 7648431
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 2.